Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhakti Chavan

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Vascular Surgery|May 21, 2021
The benefit of negative pressure dressings in vascular surgery patients with infrainguinal incisionsLaura J Meiler, Elsworth C Beach, Bhakti Chavan, et al.
Lancet (London, England)|May 26, 2024
Antimicrobial resistance survivors: calling the world to actionNour Shamas, John Kariuki, Ella Balasa, et al.
The Lancet Regional Health. Southeast Asia|December 11, 2023
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trialSanket Shah, Ranjan Kumar Nandy, Shaily S Sethi, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Vascular Surgery|May 21, 2021
The benefit of negative pressure dressings in vascular surgery patients with infrainguinal incisionsLaura J Meiler, Elsworth C Beach, Bhakti Chavan, et al.
Lancet (London, England)|May 26, 2024
Antimicrobial resistance survivors: calling the world to actionNour Shamas, John Kariuki, Ella Balasa, et al.
The Lancet Regional Health. Southeast Asia|December 11, 2023
Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trialSanket Shah, Ranjan Kumar Nandy, Shaily S Sethi, et al.
Pageof 3